
Blessie Elizabeth Nelson MBBS, DMRT
@blessienelson
Assistant Professor, General & Breast Medical Oncology | MD Anderson | Focused on Early Phase Trials, Multimodal Precision Oncology & Health Disparities
ID: 1516506999122546698
19-04-2022 20:00:28
433 Tweet
218 Followers
183 Following







Skin related side effects (rashes in particular) are not only observed with EFGR inhibitors, but also with recently developed KRAS inhibitors. Nice work being done at MD Anderson Cancer Center by the team of David S. Hong MD & Anisha B. Patel MD to ameliorate this AE for patient tolerability.

Pancreatic cancer is often diagnosed at later stages, making treatment more difficult. In the latest Cancerwise podcast episode, our experts discuss the latest research and emerging treatments from the lab and clinic. Listen here: bit.ly/3ERncxZ Anirban Maitra


👉Thanks 🙏 chadi nabhan MD, MBA, FACP for the personalized , autographed copy of his new book 📕 “The Cancer Journey” at #ThinkTank25 Sanam Loghavi, MD صنم لغوی 🔬🧬 Vivek Subbiah, MD Ruben A. Mesa, MD Vincent Rajkumar Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Sangeetha Venugopal MD,MS Hetty Carraway Mikkael A. Sekeres MD, MS Hima Atluri, MD Hannah Goulart Krish Patel



Pro tips to help with cancer related anxiety featured here at the HOPE Summit! LUNGevity Foundation


Final debate of #ASBrS2025: pN+ after neoadjuvant therapy - Dr Marie Jeanne Vrancken Peeters argued for completion #ALND while Dr Walter Weber argued for #radiation. Concluded with an expert summary by Dr Kelly Hunt Kelly K Hunt MD Anderson Cancer Center Craig Carson ASBrS Henry Kuerer




Deeply saddened that the entire team NCI Cancer Control National Cancer Institute PDQ Cancer Information has been eliminated. Our evidence-based summaries were updated throughout the year with the latest evidence and supported informed decision making between clinicians & patients across the US. 🇺🇸


Thanks to everyone who helped make my (almost) 1st year back in Colorado CU Cancer Center extraordinary! ✨ Especially true for our #melanoma team! ✨ news.cuanschutz.edu/cancer-center/… via @gotosage

🎥Blessie Elizabeth Nelson MBBS, DMRT from MD Anderson Cancer Center shares AACR Project GENIE data on metaplastic #breastcancer: high frequency of targetable mutations (TP53, PIK3CA), copy number changes, and mutual exclusivity patterns support precision therapy: ➡️ow.ly/zkq950VU06v⬅️ AACR #BCSM

VJ Oncology Blessie Elizabeth Nelson MBBS, DMRT MD Anderson Cancer Center AACR Congratulations Blessie Elizabeth Nelson MBBS, DMRT I am so proud of you 👏🏼🙌🏻
